ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Commences Clinical Evaluation
|
|
jm0000
|
57 |
19K |
5 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
57
|
19K
|
5
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Commences Clinical Evaluation
|
|
jm0000
|
57 |
19K |
4 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
57
|
19K
|
4
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Commences Clinical Evaluation
|
|
jm0000
|
57 |
19K |
2 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
57
|
19K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Commences Clinical Evaluation
|
|
jm0000
|
57 |
19K |
1 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
57
|
19K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Commences Clinical Evaluation
|
|
jm0000
|
57 |
19K |
12 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
57
|
19K
|
12
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Commences Clinical Evaluation
|
|
jm0000
|
57 |
19K |
5 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
57
|
19K
|
5
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Commences Clinical Evaluation
|
|
jm0000
|
57 |
19K |
4 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
57
|
19K
|
4
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: March 2020 Quarterly Activities and Cashflow Reports
|
|
jm0000
|
13 |
8.2K |
2 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
13
|
8.2K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: March 2020 Quarterly Activities and Cashflow Reports
|
|
jm0000
|
13 |
8.2K |
7 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
13
|
8.2K
|
7
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
1 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
64
|
28K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
3 |
12/04/20 |
12/04/20 |
ASX - By Stock
|
64
|
28K
|
3
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
6 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
64
|
28K
|
6
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
10 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
64
|
28K
|
10
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
1 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
64
|
28K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
8 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
64
|
28K
|
8
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
4 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
64
|
28K
|
4
|
|
ASX - By Stock
|
AC8 |
Re:
weeks end
|
|
jm0000
|
3 |
2.1K |
1 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
3
|
2.1K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
weeks end
|
|
jm0000
|
3 |
2.1K |
0 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
3
|
2.1K
|
0
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
5 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
64
|
28K
|
5
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
11 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
64
|
28K
|
11
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
7 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
64
|
28K
|
7
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
4 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
64
|
28K
|
4
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
6 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
64
|
28K
|
6
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
8 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
64
|
28K
|
8
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
64
|
28K
|
0
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
2 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
64
|
28K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
5 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
64
|
28K
|
5
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
jm0000
|
64 |
28K |
7 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
64
|
28K
|
7
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Receives R&D Tax Incentive Refund of $1.2m
|
|
jm0000
|
42 |
14K |
1 |
28/03/20 |
28/03/20 |
ASX - By Stock
|
42
|
14K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Receives R&D Tax Incentive Refund of $1.2m
|
|
jm0000
|
42 |
14K |
0 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
42
|
14K
|
0
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Receives R&D Tax Incentive Refund of $1.2m
|
|
jm0000
|
42 |
14K |
1 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
42
|
14K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Receives R&D Tax Incentive Refund of $1.2m
|
|
jm0000
|
42 |
14K |
9 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
42
|
14K
|
9
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Receives R&D Tax Incentive Refund of $1.2m
|
|
jm0000
|
42 |
14K |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
42
|
14K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Receives R&D Tax Incentive Refund of $1.2m
|
|
jm0000
|
42 |
14K |
3 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
42
|
14K
|
3
|
|
ASX - By Stock
|
AC8 |
Re:
Hard Shell
|
|
jm0000
|
21 |
6.6K |
3 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
21
|
6.6K
|
3
|
|
ASX - By Stock
|
AC8 |
Re:
Hard Shell
|
|
jm0000
|
21 |
6.6K |
1 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
21
|
6.6K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Hard Shell
|
|
jm0000
|
21 |
6.6K |
1 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
21
|
6.6K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann appoints Chief Medical Advisor
|
|
jm0000
|
46 |
14K |
2 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
46
|
14K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann appoints Chief Medical Advisor
|
|
jm0000
|
46 |
14K |
4 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
46
|
14K
|
4
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann appoints Chief Medical Advisor
|
|
jm0000
|
46 |
14K |
3 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
46
|
14K
|
3
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann appoints Chief Medical Advisor
|
|
jm0000
|
46 |
14K |
2 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
46
|
14K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann appoints Chief Medical Advisor
|
|
jm0000
|
46 |
14K |
1 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
46
|
14K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann appoints Chief Medical Advisor
|
|
jm0000
|
46 |
14K |
1 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
46
|
14K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann appoints Chief Medical Advisor
|
|
jm0000
|
46 |
14K |
1 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
46
|
14K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann appoints Chief Medical Advisor
|
|
jm0000
|
46 |
14K |
2 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
46
|
14K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: Change of Director's Interest Notice - K. Bates
|
|
jm0000
|
8 |
3.5K |
0 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
8
|
3.5K
|
0
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: Change of Director's Interest Notice - K. Bates
|
|
jm0000
|
8 |
3.5K |
3 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
8
|
3.5K
|
3
|
|
ASX - By Stock
|
AC8 |
Re:
Valuation: LGP vs AC8
|
|
jm0000
|
8 |
2.9K |
1 |
07/03/20 |
07/03/20 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Valuation: LGP vs AC8
|
|
jm0000
|
8 |
2.9K |
1 |
07/03/20 |
07/03/20 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Valuation: LGP vs AC8
|
|
jm0000
|
8 |
2.9K |
2 |
07/03/20 |
07/03/20 |
ASX - By Stock
|
8
|
2.9K
|
2
|
|